Zydus Lifesciences has launched Semaglutide Injection under the brand names SEMAGLYN, MASHEMA and ALTERME, upon patent expiry in India. The Drug Controller General of India (DCGI) had earlier provided ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Enable Injections, Greater ...
Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced ...
Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as “Zydus”), an innovation-led global ...
Zydus Lifesciences has announced the launch of semaglutide injection in India under the brand names Semaglyntm, Mashematm, and Altermetm, following the expiry of the drug's patent in the country.